News tagged with national cancer institute

Related topics: cancer · breast cancer · journal of the national cancer institute · patients · cancer cells

FDA approves novel treatment for hairy cell leukemia

(HealthDay)—Lumoxiti (moxetumomab pasudotox-tdfk) injection has been approved to treat certain instances of relapsed or refractory hairy cell leukemia (HCL), the U.S. Food and Drug Administration said yesterday.

Sep 15, 2018
popularity3 comments 0